99mTc-Sestamibi SPECT is a useful technique for viability detection

Scandinavian Cardiovascular Journal

Volumn 35, Issue 4, 2001, Pages 245-251

  Kaltoft, A ^a   Bottcher M ^a   Ronnow Sand N P ^a   Flo C ^a   Toftegaard, T ^a   Nielsen, T ^a   Rehling, M ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

99mTc Sestamibi SPECT; Ischemic cardiomyopathy; NH3 FDG PET; Viability

Indexed keywords

AMMONIA; FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; DIAGNOSTIC AGENT; NITROGEN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART CONTRACTION; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPOTHESIS; IMAGING SYSTEM; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RATING SCALE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ANGIOCARDIOGRAPHY; CELL SURVIVAL; COMPARATIVE STUDY; CORONARY ARTERY ATHEROSCLEROSIS; HEART MUSCLE; HEART STROKE VOLUME; MYOCARDIAL DISEASE; PHYSIOLOGY; RADIOGRAPHY; RANDOMIZATION; SCINTISCANNING; ULTRASTRUCTURE;

ADULT; AGED; AMMONIA; CELL SURVIVAL; COMPARATIVE STUDY; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; FEMALE; FLUDEOXYGLUCOSE F 18; HUMAN; MALE; MIDDLE AGE; MYOCARDIAL DISEASES; MYOCARDIUM; NITROGEN RADIOISOTOPES; RANDOM ALLOCATION; STROKE VOLUME; SUPPORT, NON-U.S. GOV'T; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 17944382462     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/14017430152581350     Document Type: Article

References (32)

1. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction
2. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography
3. Results of revascularization in patients with severe left ventricular dysfunction
4. Metabolic imaging to assess myocardial viability
5. Use and limitations of metabolic tracers labeled with positron-emitting radionuclides in the identification of viable myocardium
6. Role of thallium-201 and PET imaging in evaluation of myocardial viability and management of patients with coronary artery disease and left ventricular dysfunction
7. Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects
8. 18F]fluorodeoxyglucose
9. Effect of left ventricular function on the assessment of myocardial viability by technetium-99m sestamibi and correlation with positron emission tomography in patients with healed myocardial infarcts or stable angina pectoris, or both
10. Effect of ischemia and postischemic dysfunction on myocardial uptake of technetium-99m-labeled methoxyisobutyl isonitrile and thallium-201
11. Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability?
12. 99mTc-sestamibi uptake and retention during myocardial ischemia and reperfusion
13. 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction
14. Rest technetium 99m-sestamibi tomoscintigraphy in hibernating myocardium
15. 99mTc-sestamibi
16. Demonstration of viable, stunned myocardium with technetium-99m-sestamibi
17. Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT. Correlation with histologic and positron emission tomographic studies and functional follow-up
18. Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction
19. Comparison of thallium-201 resting redistribution with technetium-99m-sestamibi uptake and functional response to dobutamine for assessment of myocardial viability
20. Performance characteristics of a wholebody positron tomograph [published erratum appears in J Nucl Med 1989; 30(2): 268]
21. Quantitative same-day rest-stress technetium-99m-sestamibi SPECT: Definition and validation of stress normal limits and criteria for abnormality
22. Technetium 99m sestamibi in the assessment of chronic coronary artery disease
23. Comparison of sestamibi single-photon emission computed tomography with positron emission tomography for estimating left ventricular myocardial viability
24. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: Comparison of pooled data
25. Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile
26. 99mTc sestamibi in patients undergoing cardiac transplantation. A scintigraphic/pathological study
27. 99mTc-sestamibi tomography before coronary bypass graft surgery: Correlation with histopathology and postoperative improvement in cardiac function
28. Are technetium-99m-labeled myocardial perfusion agents adequate for detection of myocardial viability?
29. Sublingual isosorbide dinitrate to improve technetium-99m-teboroxime perfusion defect reversibility
30. Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrates: Feasibility and reliability for prediction of postrevascularization outcome of asynergic territories
31. Nitrate-augmented myocardial imaging for assessment of myocardial viability
32. Influence of the assessment of defect severity and intravenous nitrate administration during tracer injection on the detection of viable hibernating myocardium with data-based quantitative technetium single-photon emission computed tomography